Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Alan Murakami, M.D.

Concepts (142)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Mantle-Cell120232370.730 Why?
Lymphoma, B-Cell120239400.550 Why?
Bone Marrow1202429110.450 Why?
Guanylate Cyclase120232050.210 Why?
CARD Signaling Adaptor Proteins120231590.200 Why?
Xenograft Model Antitumor Assays4201836020.200 Why?
Asparaginase120222400.190 Why?
Tissue and Organ Harvesting120243730.180 Why?
Leukemia, B-Cell12020840.170 Why?
Leukocyte Elastase220111140.160 Why?
Proto-Oncogene Proteins c-mdm2220183680.160 Why?
Lymphoma, Extranodal NK-T-Cell12018480.150 Why?
Micro-Electrical-Mechanical Systems12016310.140 Why?
Bone Marrow Cells1202424160.130 Why?
Bone Marrow Transplantation1202426930.130 Why?
Lymphoma, T-Cell120183040.130 Why?
src-Family Kinases120185350.120 Why?
Tissue Banks120161840.120 Why?
Receptors, Antigen, B-Cell120185450.120 Why?
Neoplasms32017221700.110 Why?
Drug Screening Assays, Antitumor120167180.110 Why?
Cell Transformation, Neoplastic2202028250.110 Why?
Neoplasm, Residual1201810080.100 Why?
Antibodies, Monoclonal, Murine-Derived120156940.100 Why?
Lab-On-A-Chip Devices120164320.100 Why?
Neoplasms, Experimental1201612290.090 Why?
Agranulocytosis12011970.090 Why?
Lymphoma, Follicular120154570.090 Why?
Lymphoma, Non-Hodgkin1201813740.090 Why?
Escherichia coli1202242170.090 Why?
Hematologic Neoplasms1202118960.080 Why?
Hematopoietic Stem Cells1202133960.080 Why?
Granulocytes120115510.080 Why?
Unfolded Protein Response120112340.080 Why?
Leukemia1201615220.070 Why?
Granulocyte Precursor Cells12007490.070 Why?
Tumor Suppressor Protein p531201829170.070 Why?
Signal Transduction32020234450.070 Why?
B-Lymphocytes1202047580.070 Why?
Lymphoma1201619010.070 Why?
Practice Guidelines as Topic1202473900.070 Why?
Neutropenia220118850.070 Why?
Peptides1201843580.070 Why?
Antineoplastic Agents32018136390.060 Why?
Proto-Oncogene Proteins1201845110.060 Why?
Ambulatory Care1201627750.060 Why?
Nuclear Proteins1201857960.050 Why?
Gene Expression Regulation, Neoplastic1201885470.050 Why?
Protein Kinase Inhibitors1201856710.050 Why?
Humans1520247615040.050 Why?
Blood Cell Count120213970.050 Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 6120201200.040 Why?
Proto-Oncogene Proteins c-bcl-6120201910.040 Why?
STAT5 Transcription Factor120202650.040 Why?
Immunotherapy1201546520.040 Why?
Mice72022815250.040 Why?
Imidazolines12018180.040 Why?
Depsipeptides12018950.040 Why?
Extracellular Signal-Regulated MAP Kinases120206150.040 Why?
Neoplasm Recurrence, Local1201592800.030 Why?
Genes, myc120183900.030 Why?
Ikaros Transcription Factor120182320.030 Why?
Emergency Service, Hospital1201678790.030 Why?
Rabbits1202247720.030 Why?
Leukemia, Experimental120162250.030 Why?
Databases as Topic120174730.030 Why?
Chromosome Aberrations1202117680.030 Why?
Proto-Oncogene Proteins c-myc120209880.030 Why?
Janus Kinase 2120185600.030 Why?
Drug Therapy120185030.030 Why?
Antibodies1202224180.030 Why?
Isoquinolines120163520.030 Why?
Enzyme Activation1202035970.030 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma120162260.030 Why?
Equipment Failure Analysis120168470.030 Why?
Animals720221684590.030 Why?
Genes, p53120167120.030 Why?
Cell Differentiation12011115280.030 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive120186860.030 Why?
Drug Evaluation, Preclinical1201813340.030 Why?
Vincristine1201510360.030 Why?
Cell Line, Tumor22020169810.030 Why?
Remission Induction1201823960.030 Why?
Disease Models, Animal32018182520.030 Why?
Adenine120189870.030 Why?
Neoplasm Transplantation1201620160.030 Why?
Drug Resistance, Neoplasm2201853050.020 Why?
Mice, Inbred NOD1201618270.020 Why?
Random Allocation1201623950.020 Why?
Apoptosis1200794860.020 Why?
Patients120179070.020 Why?
Prednisone1201515630.020 Why?
Cyclophosphamide1201522180.020 Why?
Piperidines1201816560.020 Why?
Mutant Proteins120114910.020 Why?
Doxorubicin1201522240.020 Why?
Equipment Design1201635100.020 Why?
Mutation22015300520.020 Why?
Pyrazoles1201820090.020 Why?
Protein Denaturation120072420.020 Why?
Cell Lineage1201625550.020 Why?
Myelopoiesis120071340.020 Why?
Cell Cycle Proteins1201834480.020 Why?
Proteome1201618620.020 Why?
Protein Binding1201893510.020 Why?
Membrane Proteins1202278560.020 Why?
Pyrimidines1201830280.020 Why?
Treatment Outcome32018646800.020 Why?
Piperazines1201625230.020 Why?
Gene Expression1201875810.020 Why?
Disease-Free Survival1201568140.020 Why?
Molecular Targeted Therapy1201628110.010 Why?
Medical Oncology1201623210.010 Why?
Dose-Response Relationship, Drug12016107660.010 Why?
Neoplasm Proteins1201636170.010 Why?
Internet1201630920.010 Why?
Protein Folding120078700.010 Why?
Critical Care1201626960.010 Why?
Pilot Projects1201686310.010 Why?
Mice, Knockout12018144140.010 Why?
Length of Stay1201664250.010 Why?
Cells, Cultured12016189650.010 Why?
Cell Proliferation12016104450.010 Why?
Female520203926440.010 Why?
Research Design1201661800.010 Why?
Gene Expression Profiling1201694200.010 Why?
Randomized Controlled Trials as Topic12016102090.010 Why?
Mice, Transgenic1201195390.010 Why?
Phenotype12016165910.010 Why?
Male420163608040.010 Why?
Hospitalization12016107230.010 Why?
Prognosis12015296250.010 Why?
Aged220161692890.010 Why?
Mice, Inbred C57BL12011221690.010 Why?
Middle Aged220162208950.010 Why?
Adult220162211770.010 Why?
Aged, 80 and over12016589760.010 Why?
Young Adult12016592430.010 Why?
Pregnancy12011298740.000 Why?
Risk Factors12015742060.000 Why?
Adolescent12016883190.000 Why?
Retrospective Studies12015806360.000 Why?
Murakami's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (142)
Explore
_
Co-Authors (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.